Ted Burns headshot
TB

Ted Michael Burns

Professor
Unit: School of Medicine
Department: Department of Neurology
Office location and address
1415 Jefferson Park Ave
Charlottesville, Virginia 22903
Education
University of Kansas, 1994, MD
Neurology, University of Virginia
Biography

Dr. Ted M. Burns’ clinical practice focuses on neuromuscular diseases. He is the vice chair of clinical affairs in the Department of Neurology and in 2009 was awarded Endowed Chair, Harrison Distinguished Teaching Professor. He is also the head of the Neuromuscular Disorders Division and director of the Electromyography Laboratory. Dr. Burns is board-certified in both neurology and clinical neurophysiology.

Dr. Burns obtained his undergraduate degree at the University of Kansas, where he went on to earn his medical degree. He completed his residency in neurology at the University of Virginia, as well as a fellowship in neuromuscular disease and electromyography. He completed an additional fellowship in peripheral nerve disease at the Mayo Clinic. He returned to UVA to join the faculty in 2002.

Dr. Burns has over 100 publications. His academic interests include the development and validation of user-friendly outcome measures for myasthenia gravis (MG) and other neuromuscular disorders. He is also interested in podcasting for the education of physicians, patients and families and is creator and editor of the Neurology journal’s weekly podcast and the American Association of Neuromuscular and Electrodiagnostic Medicine’s podcast. He is also creator of the Myasthenia Gravis Foundation’s podcast series designed to educate patients and families about practical aspects of MG.

Dr. Burns is married and has three children. 

MD-NEUR Exploratory Study of Biomarkers Predicting Response to Immunosuppressives in Myasthenia Gravis
Source: Duke University
September 01, 2015 – July 31, 2019
MD-NEUR Clinical Research in ALS & related disorders for Therapeutic Development (CREATE) per patient YR05
Source: University Of Miami
July 01, 2018 – June 30, 2019
Multi-Site Neurological Disease Biorepository
Source: Duke University
August 02, 2018 – June 30, 2019
MD-NEUR Clinical Research Site for the Network of Excellence in Neuroscience Clin. Trials
Source: U.S. NIH Institute of Neurological Disorders & Str
September 30, 2011 – November 30, 2018
MD-NEUR A Phase II Trial of Rituximab in Myasthenia Gravis
Source: Massachusetts General Hospital
April 02, 2014 – August 31, 2018
MD-NEUR NeuroNEXT NN104 study
Source: Massachusetts General Hospital
March 09, 2015 – August 31, 2018
MD-NEUR Consulting agreement between Ted BUrns and CSL Behring Myasthonia gravis and CDIP
Source: Csl Behring L.L.C.
October 08, 2015 – December 31, 2017
MD-NEUR Clinical Research in ALS & related disorders for Therapeutic Development (CREATE) per patient
Source: University Of Miami
July 01, 2015 – June 30, 2017
MD-NEUR Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
Source: University of Kansas Medical Center Research Insti
July 01, 2014 – March 31, 2017
MD-NEUR Intravenous Immunoglobulin (IVIg) Treatment-Related Fluctuations in Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Patients Using Daily Grip Strength Measurements (GRIPPER)
Source: Regents of the University of Minnesota
September 02, 2015 – December 31, 2016
MD-NEUR Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)
Source: University Of Miami
July 01, 2016 – December 31, 2016
MD-NEUR Clinical Research in ALS & related disorders for Therapeutic Development (CREATE)
Source: University Of Miami
July 01, 2015 – June 30, 2016
MD-NEUR Consulting Agreement with Walgreens
Source: Walgreens Infusion Services, Inc.
December 15, 2014 – December 15, 2015
MD-NEUR Consulting Agreement for Ted Burns with UCB CELLTECH
Source: UCB Celltech
September 02, 2014 – March 09, 2015
Phase II Trial of Methotrexate in Myasthenia Gravis
Source: University of Kansas Medical Center Research Insti
April 15, 2009 – August 31, 2013
Knopp KNS211 Investigational Study of KNS760704 for Use in Patients with Amyotrophic Lateral Sclerosis
Source: Knopp Neurosciences Inc.
August 10, 2009 – May 07, 2013
Study of Safety and Efficacy of Dexpramipexole in Subjects with Amyotrophic Lateral Sclerosis
Source: Biogen
March 08, 2011 – March 08, 2013
  • 2005-2018 Best Doctors in America® List 
  • 2009 Endowed Chair, Harrison Distinguished Teaching Associate Professor in Neurology
  • 2006 Master Education Award, University of Virginia School of Medicine
  • 2005 Dean's Teaching Award of Excellence, University of Virginia School of Medicine
  • "Doctor of the Year" Award, Myasthenia Gravis Foundation of America